Profil
Sara Weymer is currently the Director of Clinical Program Management at ZZ Biotech LLC and the Vice President of Clinical Operations at Boundless Bio, Inc. She previously worked as the Executive Director and Head of Clinical Operations at Fate Therapeutics, Inc.
Aktive Positionen von Sara Weymer
| Unternehmen | Position | Beginn |
|---|---|---|
| BOUNDLESS BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.06.2022 |
ZZ Biotech LLC
 ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sara Weymer
| Unternehmen | Position | Ende |
|---|---|---|
| FATE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ZZ Biotech LLC
ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Health Technology |
